by Marco Albrecht | Jul 1, 2022 | Corporate
Sergei Vavilov joins esqLABS Sergei Vavilov, a pharmacometrician with experience in bioinformatics, data science, and systems modeling, joined esqLABs on 1st July. WE WELCOME SERGEI TO THE TEAM! Sergei Vavilov joins esqLABS Sergei will help advance the...
by Stephan Schaller | Feb 1, 2022 | Corporate
René Geci joins esqLABS From January 1, 2022, René Geci, a Systems Biologist with an MSc in Systems Biology from Heidelberg University (Germany) is reinforcing esqLABS. WE WELCOME RENÉ TO THE TEAM! René Geci joins esqLABS René Geci is a Systems Biologist who...
by Stephan Schaller | Jan 1, 2022 | Corporate
Dr. Alicia Paini joins esqLABS From October 1, 2021, Dr. Alicia Paini, a European Registered Toxicologist with a Ph.D. in Toxicology from Wageningen University (Netherlands) is reinforcing esqLABS. WE WELCOME ALICIA TO THE TEAM! Dr. Alicia Paini joins esqLABS...
by Felix MIL | Dec 22, 2021 | Corporate
2021 in Review for the esqLABS Software Development Team 2021 in Review for the esqLABS Software Development Team 2021 was a busy year for the esqLABS software team, with lot of effort invested to deliver the new version 10 of the open-source modeling software...
by Luis Franco | Dec 22, 2021 | Corporate
2021 in Review for the esqLABS Team 2021 in Review for the esqLABS Team In 2021, for our fourth year, the esqLABS team has again grown in numbers. After doubling our size in 2020, we were again able to grow our esqLABS family by 50%, with new colleagues, and exciting...
by Stephan Schaller | Sep 10, 2021 | Corporate
esqLABS provides training to US FDA Scientists August 2021: esqLABS provides training to US FDA Scientists on the use of the OSP Suite (PK-Sim® and MoBi®) for PBPK and QSP modeling and simulation esqLABS has had the privilege to provide a detailed 3-day...
